Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea.
Do Yeun KimHyerim HaSeung Jin BaeJin Hyoung KangPublished in: Journal of Korean medical science (2021)
The Korean oncologists recognized the necessity for the clinical application of VF. Further discussion between the stakeholders should be followed to alleviate the financial burden through the value-based decision making of cancer drugs.